Financial institutions including Goldman Sachs, Bank of America, and Mizuho Securities made inquiries regarding competitive positioning and activity related to povorcitinib and INCA033989.

The entities involved

• Goldman Sachs →

  American investment bank

  • US-Iran truce aims to reopen Strait of Hormuz amid global monetary policy shifts and oil price drops.Mon 17:37
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• Incyte →

  American pharmaceutical company

  • Incyte, a biotech company based in Wilmington, outperformed the biotech ETF.Thu 13:11
• Bank of America →

  American multinational banking and financial services corporation

  • Both Bank of America and Deloitte have addressed current treasury management trends.Mon 14:26
  • Disputes intensified over foreign policy comparisons in the Middle East, driving oil market volatility.Mon 14:11
• Mizuho Securities →

  Japanese investment banking company

  Nothing else this week.

Related events

• Mizuho Securities boosted its target price on Dominion Energy stock and filed with the SEC regarding stock purchases.Aug 16
• Mizuho Securities boosted its rating on The Cheesecake Factory stock, which also filed with the SEC and trades on Nasdaq.Aug 26
• Mizuho Securities lifted its price target and disclosed a transaction involving Guardant Health in an SEC filing.Aug 19
• Mizuho, Bank of America, and TD Cowen have issued rating and price target changes for Texas Instruments.Aug 25
• Morgan Stanley downgraded GE Vernova shares, while Mizuho lifted its price objective and JPMorgan Chase upped its target price.Sep 11